8:00 - 19:00

Working hours MON. - FRI.

EU’s drug regulator backs ‘safe and effective’ AstraZeneca vaccine By Reuters

By Anthony Deutsch and Toby Sterling AMSTERDAM (Reuters) - The EU's drug watchdog said on Thursday it is still convinced the benefits of AstraZeneca (NASDAQ:AZN)'s COVID-19 vaccine outweigh the risks following an investigation into reports of blood clots that prompted more than a dozen nations to suspend its use. The European Medicines Agency (EMA) director Emer Cooke said the watchdog could not...

Continue reading

Explainer: How worried should we be about reports of blood clots and AstraZeneca’s vaccine? By Reuters

By Ludwig Burger and Matthias Blamont FRANKFURT/PARIS (Reuters) - Europe's medicines watchdog concluded on Thursday that AstraZeneca (NASDAQ:AZN)'s coronavirus vaccine still far outweighed any risks after investigating reports of rare blood clotting disorders but said it would add a warning to the product leaflet. "A causal link with the vaccine is not proven, but is possible and deserves further analysis," the European...

Continue reading

Nikola Slumps As Partner Cuts Stake in Half By Investing.com

By Christiana SciaudoneInvesting.com --  Nikola slumped more than 6% after a strategic partner said it's dumping shares. Green Nikola Holdings/Hanwha said in a filing it would sell half of its 22 million shares in the company. The South Korean company told Reuters it will use the proceeds to invest in hydrogen-related businesses. It's yet another blow for the hydrogen truck company, whose founder...

Continue reading

Five Below Beats Expectations But Offers No Guidance on Year, Shares Fall By Investing.com

Dhirendra Tripathi Investing.com – Despite a blowout quarter, management's lack of full-year guidance sank Five Below (NASDAQ:FIVE) shares on Thursday. The stock fell 3% in morning trade. A robust outlook for February  through April was also not adequate to sooth traders’ nerves. Berenberg Bank analyst Brian McNamara maintained a hold rating on the stock and a price target of $143. This is a 24%...

Continue reading

Indian court restrains Future chief from selling assets in dispute with Amazon By Reuters

NEW DELHI (Reuters) - An Indian court on Thursday restrained Future Group chief Kishore Biyani from selling his assets following Amazon.com Inc (NASDAQ:AMZN)'s challenge against the Indian group's $3.4 billion retail assets sale. Amazon is locked in a dispute with its warring partner Future which it says allegedly violated certain contracts by selling its retail assets to market leader Reliance Industries last...

Continue reading

U.S. Treasury Yields Jump, 30-year at Highest Since 2019 By Investing.com

Dhirendra Tripathi Investing.com – The yields on U.S. Treasury bonds jumped overnight despite the Federal Reserve’s assertion Wednesday that an interest rate hike is not anywhere on the horizon. The United States 10-Year touched a 14-month high of 1.75% while that on the United States 30-Year bond hit 2.51%. The 30-year yield is its highest since August 2019. Market makers are holding on...

Continue reading
en_GBEnglish